REGULATING CEREBROSPINAL FLUID FORMATION
REGULATING CEREBROSPINAL FLUID FORMATION
批准号:
2266303
负责人:
BARRY J. HOFFER
金额:
$14.34万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-04-01 至 1995-03-31
中文摘要
改进减少脑脊液产生的医疗手段将是主要的好处
适用于颅内压升高的患者。这样的病人
包括急性头部创伤,颅内出血,一些肿瘤,
和故障的脑脊液分流管。创伤是第四大诱因
死亡,其中高达70%的死亡是由于头部受伤。致命的
头部损伤与颅内压升高有关,通常在前3-5个月内
几天。能够通过减少脑脊液产生来降低颅内压的药物可能
拯救一些这样的生命。该项目的目标是进一步发展
我们对脑脊液产生的神经控制的认识
脑脊液(CSF)由脉络丛注入。目前已知,有同情心
Tone抑制脑脊液的分泌。我们实验室的初步数据
表明抗精神病药或抗精神病药物也会导致
脑脊液的净产量。据推测,他的受体
负责调节这一效应的神经元定位于脉络丛
和/或交感神经节。我们将研究这两种受体
用~3H-SCH-23390和~3H-Mesulergine标记。其中之一是5-HT1c
受体,但尚不清楚第二种受体的亚型
是。许多药物对这两种受体都有很高的亲和力。药理作用
后一种受体的特性将使用受体进行
第二信使分析。主要的努力将是研究调制
这些受体上的激动剂和拮抗剂产生的脑脊液。老鼠
会在枕大池插管时被急诊处理
与同位素稀释法进行比较。用SUBPLE治疗的大鼠
颈神经节切除术将被研究以确定某些药物是否起作用
通过调节交感神经的音调。确定药物的慢性疗效
这些药物会减少脑脊液的产生,这些药物将通过
植入小型泵并进行测试以确定是否已形成耐受性
对这种药物的急性给药。对脑脊液交叉耐受的证据-
将在慢性用药的大鼠中寻求调节作用
抗精神病药物,并与另一种药物尖锐地挑战,如
糖皮质激素。评估降低脑脊液的药物的可能性
产生通过减少流向脉络丛的血液而起作用,14C-
将使用碘安替比林技术测量区域血流量
用药前后比较。按照计划,那只很有前途的动物
后续的研究将有临床研究建议。
英文摘要
Improved medical means of reducing CSF production would be of major benefit
to patients with increased intracranial pressure (ICP). Such patients
include those with acute head trauma, intracranial hemorrhage, some tumors,
and malfunctioning CSF shunts. Trauma is the fourth leading cause of
death, and up to 70% of these deaths are due to the head injury. Fatal
head injury is associated with increased ICP, usually within the first 3-5
days. Drugs capable of reducing ICP, by reducing CSF production, might
save some of these lives. The goal of this project is to develop further
our understanding of the neural control of the production of cerebrospinal
fluid (CSF) by the choroid plexus. It is currently known that sympathetic
tone inhibits secretion of CSF. Preliminary data from our laboratory
suggest that neuroleptics, or antipsychotic drugs, also cause a decrease in
the net production of CSF. It is hypothesized that he receptors
responsible for mediating this effect are localized to the choroid plexus
and/or the sympathetic ganglia. We will study both of the receptors
labeled by 3H-SCH-23390 and 3H-mesulergine. One of these is the 5-HT1c
receptor, but it is not yet clear what subtype of receptor the second one
is. Many drugs have high affinity for both receptors. Pharmacological
characterization of the latter receptor will be carried out using receptor
and second messenger assays. The major effort will be to study modulation
of CSF production by agonists and antagonists at these receptors. Rats
will be treated acutely with which the cisterna magna is cannulated will be
compared with the isotope dilution method. Rats treated with superior
cervical ganglionectomy will be studied to determine whether some drugs act
by modulating sympathetic tone. To determine the chronic efficacy of drugs
which decrease CSF production, rats will be treated with such drugs via
implanted minipumps and tested to determine whether tolerance has developed
to an acute administration of the drug. Evidence of crosstolerance to CSF-
modulating effects will be sought in rats treated chronically with
neuroleptics and challenged acutely with another agent, such as a
glucocorticoid. To evaluate the possibility that drugs which reduce CSF
production act by reducing blood flow to the choroid plexus, the 14C-
iodoantipyrine technique will be used to measure regional blood flow both
before and after drug administration. It is planned that promising animal
studies will be followed up by clinical study proposals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHARMACOLOGICAL CORRELATES OF AGING IN BRAIN CELL GRAFTS
-
批准号:6311452
-
项目类别:
-
资助金额:$14.76万
-
财政年份:2000
-
负责人:BARRY J. HOFFER
-
依托单位:
PHARMACOLOGICAL CORRELATES OF AGING IN BRAIN CELL GRAFTS
-
批准号:6097978
-
项目类别:
-
资助金额:$14.76万
-
财政年份:1999
-
负责人:BARRY J. HOFFER
-
依托单位:
PHARMACOLOGICAL CORRELATES OF AGING IN BRAIN CELL GRAFTS
-
批准号:6267219
-
项目类别:
-
资助金额:$14.19万
-
财政年份:1998
-
负责人:BARRY J. HOFFER
-
依托单位:
FUNCTION OF CNS NEURAL GRAFTS
-
批准号:6112032
-
项目类别:
-
资助金额:$12.74万
-
财政年份:1998
-
负责人:BARRY J. HOFFER
-
依托单位:
FETAL TISSUE TRANSPLANT AND OTHER GENE EXPRESSION SYSTEMS
-
批准号:6111440
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:BARRY J. HOFFER
-
依托单位:
FETAL TISSUE TRANSPLANT AND OTHER GENE EXPRESSION SYSTEMS
-
批准号:6243058
-
项目类别:
-
资助金额:$21.21万
-
财政年份:1997
-
负责人:BARRY J. HOFFER
-
依托单位:
FUNCTION OF CNS NEURAL GRAFTS
-
批准号:6243412
-
项目类别:
-
资助金额:$12.28万
-
财政年份:1997
-
负责人:BARRY J. HOFFER
-
依托单位:
PHARMACOLOGICAL CORRELATES OF AGING IN BRAIN CELL GRAFTS
-
批准号:6233990
-
项目类别:
-
资助金额:$13.8万
-
财政年份:1997
-
负责人:BARRY J. HOFFER
-
依托单位:
AMINERGIC FUNCTION IN AGING AND ALZHEIMER'S DISEASE
-
批准号:3090877
-
项目类别:
-
资助金额:$9.47万
-
财政年份:1992
-
负责人:BARRY J. HOFFER
-
依托单位:
COMPLEX I IN PARKINSONS DISEASE
-
批准号:3415971
-
项目类别:
-
资助金额:$21.77万
-
财政年份:1991
-
负责人:BARRY J. HOFFER
-
依托单位:
SCIENTIFIC EVALUATION AND PLANNING
-
批准号:3554695
-
项目类别:
-
资助金额:$4.0万
-
财政年份:1990
-
负责人:BARRY J. HOFFER
-
依托单位:
SCIENTIFIC EVALUATION AND PLANNING
-
批准号:3554697
-
项目类别:
-
资助金额:$4.0万
-
财政年份:1990
-
负责人:BARRY J. HOFFER
-
依托单位:
SCIENTIFIC EVALUATION AND PLANNING
-
批准号:3554696
-
项目类别:
-
资助金额:$2.0万
-
财政年份:1990
-
负责人:BARRY J. HOFFER
-
依托单位:
PHARMACOLOGICAL SUBSTRATES IN AGING
-
批准号:3090882
-
项目类别:
-
资助金额:$47.79万
-
财政年份:1984
-
负责人:BARRY J. HOFFER
-
依托单位:
PHARMACOLOGICAL SUBSTRATES IN AGING
-
批准号:3090878
-
项目类别:
-
资助金额:$33.14万
-
财政年份:1984
-
负责人:BARRY J. HOFFER
-
依托单位:
AMINERGIC FUNCTION IN AGING AND ALZHEIMERS DISEASE
-
批准号:2048871
-
项目类别:
-
资助金额:$87.28万
-
财政年份:1984
-
负责人:BARRY J. HOFFER
-
依托单位:
PHARMACOLOGICAL SUBSTRATES IN AGING
-
批准号:3090879
-
项目类别:
-
资助金额:$35.31万
-
财政年份:1984
-
负责人:BARRY J. HOFFER
-
依托单位:
AMINERGIC FUNCTION IN AGING AND ALZHEIMERS DISEASE
-
批准号:3090883
-
项目类别:
-
资助金额:$73.55万
-
财政年份:1984
-
负责人:BARRY J. HOFFER
-
依托单位:
PHARMACOLOGICAL SUBSTRATES IN AGING
-
批准号:3090881
-
项目类别:
-
资助金额:$53.53万
-
财政年份:1984
-
负责人:BARRY J. HOFFER
-
依托单位:
AMINERGIC FUNCTION IN AGING AND ALZHEIMERS DISEASE
-
批准号:3090874
-
项目类别:
-
资助金额:$70.33万
-
财政年份:1984
-
负责人:BARRY J. HOFFER
-
依托单位:
海外基金